We also demonstrated no correlation between H2AX overexpression and FIGO stage, corroborating the study of 87 epithelial OC (EOC) patients, where γ-H2AX immunostaining was not significantly correlated with age, histopathological type, tumour differentiation, lymph node metastasis, FIGO stage or size of residual disease [21]. The gene discussed is H2AX; the disease is metastatic malignant neoplasm in the lymph nodes.